A detailed history of Vanguard Group Inc transactions in Orasure Technologies Inc stock. As of the latest transaction made, Vanguard Group Inc holds 5,409,028 shares of OSUR stock, worth $23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,409,028
Previous 5,309,456 1.88%
Holding current value
$23 Million
Previous $43.5 Million 23.59%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$6.08 - $8.28 $605,397 - $824,456
99,572 Added 1.88%
5,409,028 $33.3 Million
Q4 2023

Feb 14, 2024

SELL
$5.13 - $8.35 $445,432 - $725,022
-86,829 Reduced 1.61%
5,309,456 $43.5 Million
Q3 2023

Nov 14, 2023

BUY
$4.4 - $6.91 $283,214 - $444,775
64,367 Added 1.21%
5,396,285 $32 Million
Q2 2023

Aug 14, 2023

BUY
$4.88 - $7.39 $848,861 - $1.29 Million
173,947 Added 3.37%
5,331,918 $26.7 Million
Q1 2023

May 15, 2023

BUY
$4.66 - $6.52 $134,646 - $188,388
28,894 Added 0.56%
5,157,971 $31.2 Million
Q4 2022

Feb 10, 2023

BUY
$4.26 - $5.29 $58,089 - $72,134
13,636 Added 0.27%
5,129,077 $24.7 Million
Q3 2022

Nov 14, 2022

BUY
$2.72 - $4.61 $157,920 - $267,651
58,059 Added 1.15%
5,115,441 $19.4 Million
Q2 2022

Aug 12, 2022

BUY
$2.71 - $7.12 $126,600 - $332,617
46,716 Added 0.93%
5,057,382 $13.7 Million
Q1 2022

May 13, 2022

BUY
$6.62 - $9.33 $734,263 - $1.03 Million
110,916 Added 2.26%
5,010,666 $34 Million
Q4 2021

Feb 14, 2022

BUY
$8.3 - $11.29 $1.15 Million - $1.56 Million
137,963 Added 2.9%
4,899,750 $42.6 Million
Q3 2021

Nov 12, 2021

SELL
$9.73 - $13.38 $14,964 - $20,578
-1,538 Reduced 0.03%
4,761,787 $53.9 Million
Q2 2021

Aug 13, 2021

BUY
$9.02 - $11.68 $43 Million - $55.6 Million
4,763,325 New
4,763,325 $48.3 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $309M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.